UBS Group
SBC

UBS Group’s SBC Medical Group SBC Stock Holding History

UBS Group’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
4,917
+1,183
+32% +$4.01K ﹤0.01% 8330
2026
Q1 		$15.6K Sell
3,734
-2,030
-35% -$8.47K ﹤0.01% 8112
2025
Q4 		$24.8K Buy
5,764
+3,503
+155% +$13.4K ﹤0.01% 7639
2025
Q3 		$9.81K Sell
2,261
-130
-5% -$586 ﹤0.01% 8576
2025
Q2 		$11.1K Sell
2,391
-58,952
-96% -$233K ﹤0.01% 8800
2025
Q1 		$196K Buy
61,343
+37,604
+158% +$171K ﹤0.01% 6579
2024
Q4 		$132K Buy
23,739
+20,529
+640% +$140K ﹤0.01% 6702
2024
Q3 		$25.6K Buy
3,210
+1,970
+159% +$22.9K ﹤0.01% 7223
2024
Q2 		$16.2K Buy
1,240
+1,189
+2,331% +$15.9K ﹤0.01% 7441
2024
Q1 		$638 Buy
51
+50
+5,000% +$573 ﹤0.01% 8432
2023
Q4 		$11 Sell
1
-57
-98% -$610 ﹤0.01% 9113
2023
Q3 		$619 Buy
58
+48
+480% +$506 ﹤0.01% 8375
2023
Q2 		$103 Sell
10
-4,795
-100% -$49.5K ﹤0.01% 8504
2023
Q1 		$50.1K Buy
4,805
+4,705
+4,705% +$48.6K ﹤0.01% 6454
2022
Q4 		$1.02K Buy
+100
New +$1.01K ﹤0.01% 9989

Other funds holding SBC

LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group's SBC Position: Q2 2026 in Review

UBS Group increased its SBC Medical Group (SBC) stake by 32% in Q2 2026, buying an estimated $4.01K and bringing the position to 4,917 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8330.

UBS Group first reported a position in SBC in Q4 2022 and has held it in 15 quarters since. The position peaked at $196K in Q1 2025. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • UBS Group held 4,917 shares of SBC Medical Group worth $15.1K as of Q2 2026.
  • UBS Group bought 1,183 SBC Medical Group shares in Q2 2026, an estimated $4.01K.
  • SBC Medical Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8330 holding.
  • UBS Group first reported a position in SBC Medical Group in Q4 2022 and has held it in 15 quarters since.
  • UBS Group's SBC Medical Group position peaked at $196K in Q1 2025.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.